Insulin dosing for fat and protein in people with Type 1 Diabetes using insulin injections.

Not Applicable

Completed

• Conditions: Type 1 Diabetes; Diet and Nutrition - Other diet and nutrition disorders; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12618002030257
• Lead Sponsor: Diabetes Australia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-12-18
• Study Completion: 2020-04-08
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 27

Inclusion Criteria

Diagnosed with T1D for greater than 1 yr
Treated with multiple daily insulin injection therapy ( 4 injections/ day) for greater than 6 mo
Glycated haemoglobin less than or equal to 8.0% (64 mmol/mol)
Non- Obese

Exclusion Criteria

•Presence of any other major medical condition
•Allergies/ intolerances to dairy, nuts, fructose, soy products
•Evidence of complications of diabetes e.g. Gastroparesis
•Oral glycaemic medications

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome variable of this study is the mean post- prandial glucose excursion. Participant glucose levels will be monitored continuously for 5 hours post- meal consumption using a continuous glucose monitor. [30-minute interval from baseline (t=0) to 300 minutes post- test meal consumption.]